Literature DB >> 8490832

Association of expression of blood group-related carbohydrate antigens with prognosis in breast cancer.

T Narita1, H Funahashi, Y Satoh, T Watanabe, J Sakamoto, H Takagi.   

Abstract

BACKGROUND: It has been thought that carbohydrate antigens, especially Lewis (Le) blood group antigens, are cancer-related antigens.
METHODS: The authors conducted immunohistochemical studies to investigate the expression of seven different types of Le carbohydrate antigens in breast cancer tissue and their usefulness as an indicator of the degree of malignancy and as a prognostic factor.
RESULTS: When this expression was compared in the cancerous portion of 300 breast cancers and noncancerous mammary ductal epithelium in each of the patients, reduced expression of type 1 carbohydrate antigens and increased expression of type 2 carbohydrate antigens were found in the cancerous portions. No correlation was detected between the antigen expression and clinicopathologic factors. The prognosis of patients in whom type 2 carbohydrate antigens were increased in the cancerous portion, especially Lex (19.7% of patients) and sialyl Lex-i (20.3% of patients), was poorer than in patients in whom they were not increased (P < 0.01).
CONCLUSIONS: The relative expression of type 2 carbohydrate antigens in breast cancer tissue seems capable of serving as a prognostic factor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8490832     DOI: 10.1002/1097-0142(19930515)71:10<3044::aid-cncr2820711026>3.0.co;2-r

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  18 in total

1.  Adhesion of Human Breast Cancer Cells to Vascular Endothelium Mediated by Sialyl Lewis &supx; /E-selectin.

Authors: 
Journal:  Breast Cancer       Date:  1996-03-29       Impact factor: 4.239

Review 2.  Blood group antigens: molecules seeking a function?

Authors:  P Greenwell
Journal:  Glycoconj J       Date:  1997-02       Impact factor: 2.916

Review 3.  Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer.

Authors:  R Kannagi
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

4.  Selectin ligands on human melanoma cells.

Authors:  N Miller; R G Vile; I R Hart
Journal:  Glycoconj J       Date:  1996-02       Impact factor: 2.916

5.  Blood type, hormone receptor status, HER2/neu status, and survival in breast cancer: a retrospective study exploring relationships in a phenotypically well-defined cohort.

Authors:  Eiko Klimant; Ingrid Glurich; Bickol Mukesh; Adedayo A Onitilo
Journal:  Clin Med Res       Date:  2011-01-24

6.  Fucosylation and gastrointestinal cancer.

Authors:  Kenta Moriwaki; Eiji Miyoshi
Journal:  World J Hepatol       Date:  2010-04-27

7.  Metabolic inhibition of sialyl-Lewis X biosynthesis by 5-thiofucose remodels the cell surface and impairs selectin-mediated cell adhesion.

Authors:  Wesley F Zandberg; Jayakanthan Kumarasamy; B Mario Pinto; David J Vocadlo
Journal:  J Biol Chem       Date:  2012-09-27       Impact factor: 5.157

Review 8.  Sweetening the pot: adding glycosylation to the biomarker discovery equation.

Authors:  Penelope M Drake; Wonryeon Cho; Bensheng Li; Akraporn Prakobphol; Eric Johansen; N Leigh Anderson; Fred E Regnier; Bradford W Gibson; Susan J Fisher
Journal:  Clin Chem       Date:  2009-12-03       Impact factor: 8.327

Review 9.  Tumour-associated carbohydrate antigens in breast cancer.

Authors:  Aurélie Cazet; Sylvain Julien; Marie Bobowski; Joy Burchell; Philippe Delannoy
Journal:  Breast Cancer Res       Date:  2010-06-08       Impact factor: 6.466

10.  Expression of the CD15 antigen (Lewis x) in breast cancer.

Authors:  S A Brooks; A J Leathem
Journal:  Histochem J       Date:  1995-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.